CA Stock MarketDetailed Quotes

METX ME Therapeutics Holding Inc

Watchlist
  • 4.000
  • -0.050-1.23%
15min DelayMarket Closed Jan 8 15:56 ET
100.76MMarket Cap-80.00P/E (TTM)

ME Therapeutics Holding Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
35.72%1.33M
-16.65%324.77K
-1.28%509.86K
310.29%145.07K
475.22%346.76K
624.06%977.37K
389.67K
516.45K
35.36K
60.28K
Selling and administrative expenses
11.68%1.06M
-28.15%279.8K
-14.95%418.31K
91.70%63.73K
396.55%299.34K
877.06%950.21K
--389.43K
--491.85K
--33.24K
--60.28K
-General and administrative expense
11.68%1.06M
-28.15%279.8K
-14.95%418.31K
91.70%63.73K
396.55%299.34K
877.06%950.21K
--389.43K
--491.85K
--33.24K
--60.28K
Research and development costs
1,050.65%312.02K
19,880.89%44.96K
383.55%118.9K
3,769.12%81.33K
--66.83K
-50.40%27.12K
--225
--24.59K
--2.1K
----
Depreciation amortization depletion
-20.41%39
-25.00%9
-16.67%10
-15.38%11
--9
-19.67%49
--12
--12
--13
----
-Depreciation and amortization
-20.41%39
-25.00%9
-16.67%10
-15.38%11
--9
-19.67%49
--12
--12
--13
----
Other operating expenses
---46.78K
--0
---27.36K
----
---19.42K
----
----
----
----
----
Operating profit
-35.72%-1.33M
16.65%-324.77K
1.28%-509.86K
-310.29%-145.07K
-475.22%-346.76K
-624.06%-977.37K
-389.67K
-516.45K
-35.36K
-60.28K
Net non-operating interest income (expenses)
705.70%31.82K
138.55%12.73K
136.21%13.87K
158.19%1.57K
29.11%3.65K
136.56%3.95K
5.34K
5.87K
-2.71K
2.82K
Non-operating interest income
178.83%31.82K
138.55%12.73K
136.21%13.87K
671.57%1.57K
29.11%3.65K
--11.41K
--5.34K
--5.87K
--204
--2.82K
Non-operating interest expense
--0
--0
--0
--0
--0
-30.91%7.46K
--0
--0
--2.91K
----
Other net income (expenses)
-5.55M
-2.56M
-2.98M
Special income (charges)
--0
--0
--0
----
----
---5.57M
----
----
----
----
-Less:Restructuring and mergern&acquisition
--0
--0
--0
----
----
--5.57M
----
----
----
----
Other non-operating income (expenses)
----
----
----
----
----
--20K
--3M
---2.98M
----
----
Income before tax
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
-38.06K
-57.46K
Income tax
Earnings from equity interest net of tax
Net income
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
-38.06K
-57.46K
Net income continuous operations
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
---2.95M
---3.49M
---38.06K
---57.46K
Noncontrolling interests
Net income attributable to the company
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
-38.06K
-57.46K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
-38.06K
-57.46K
Diluted earnings per share
81.93%-0.05
92.00%-0.01
86.74%-0.02
-509.01%-0.01
-303.39%-0.01
-4,299.75%-0.2767
-0.1251
-0.1508
-0.0016
-0.0025
Basic earnings per share
81.93%-0.05
92.00%-0.01
86.74%-0.02
-509.01%-0.01
-303.39%-0.01
-4,299.75%-0.2767
-0.1251
-0.1508
-0.0016
-0.0025
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Aug 31, 2024 (Q4)Aug 31, 2024 (Q3)May 31, 2024 (Q2)Feb 29, 2024 (Q1)Nov 30, 2023 (FY)Aug 31, 2023 (Q4)Aug 31, 2023 (Q3)May 31, 2023 (Q2)Feb 28, 2023 (Q1)Dec 31, 2022
Total revenue 0 0 0 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense 35.72%1.33M -16.65%324.77K -1.28%509.86K 310.29%145.07K 475.22%346.76K 624.06%977.37K 389.67K 516.45K 35.36K 60.28K
Selling and administrative expenses 11.68%1.06M -28.15%279.8K -14.95%418.31K 91.70%63.73K 396.55%299.34K 877.06%950.21K --389.43K --491.85K --33.24K --60.28K
-General and administrative expense 11.68%1.06M -28.15%279.8K -14.95%418.31K 91.70%63.73K 396.55%299.34K 877.06%950.21K --389.43K --491.85K --33.24K --60.28K
Research and development costs 1,050.65%312.02K 19,880.89%44.96K 383.55%118.9K 3,769.12%81.33K --66.83K -50.40%27.12K --225 --24.59K --2.1K ----
Depreciation amortization depletion -20.41%39 -25.00%9 -16.67%10 -15.38%11 --9 -19.67%49 --12 --12 --13 ----
-Depreciation and amortization -20.41%39 -25.00%9 -16.67%10 -15.38%11 --9 -19.67%49 --12 --12 --13 ----
Other operating expenses ---46.78K --0 ---27.36K ---- ---19.42K ---- ---- ---- ---- ----
Operating profit -35.72%-1.33M 16.65%-324.77K 1.28%-509.86K -310.29%-145.07K -475.22%-346.76K -624.06%-977.37K -389.67K -516.45K -35.36K -60.28K
Net non-operating interest income (expenses) 705.70%31.82K 138.55%12.73K 136.21%13.87K 158.19%1.57K 29.11%3.65K 136.56%3.95K 5.34K 5.87K -2.71K 2.82K
Non-operating interest income 178.83%31.82K 138.55%12.73K 136.21%13.87K 671.57%1.57K 29.11%3.65K --11.41K --5.34K --5.87K --204 --2.82K
Non-operating interest expense --0 --0 --0 --0 --0 -30.91%7.46K --0 --0 --2.91K ----
Other net income (expenses) -5.55M -2.56M -2.98M
Special income (charges) --0 --0 --0 ---- ---- ---5.57M ---- ---- ---- ----
-Less:Restructuring and mergern&acquisition --0 --0 --0 ---- ---- --5.57M ---- ---- ---- ----
Other non-operating income (expenses) ---- ---- ---- ---- ---- --20K --3M ---2.98M ---- ----
Income before tax 80.14%-1.29M 89.41%-312.04K 85.81%-495.99K -276.99%-143.49K -497.14%-343.11K -4,372.64%-6.52M -2.95M -3.49M -38.06K -57.46K
Income tax
Earnings from equity interest net of tax
Net income 80.14%-1.29M 89.41%-312.04K 85.81%-495.99K -276.99%-143.49K -497.14%-343.11K -4,372.64%-6.52M -2.95M -3.49M -38.06K -57.46K
Net income continuous operations 80.14%-1.29M 89.41%-312.04K 85.81%-495.99K -276.99%-143.49K -497.14%-343.11K -4,372.64%-6.52M ---2.95M ---3.49M ---38.06K ---57.46K
Noncontrolling interests
Net income attributable to the company 80.14%-1.29M 89.41%-312.04K 85.81%-495.99K -276.99%-143.49K -497.14%-343.11K -4,372.64%-6.52M -2.95M -3.49M -38.06K -57.46K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 80.14%-1.29M 89.41%-312.04K 85.81%-495.99K -276.99%-143.49K -497.14%-343.11K -4,372.64%-6.52M -2.95M -3.49M -38.06K -57.46K
Diluted earnings per share 81.93%-0.05 92.00%-0.01 86.74%-0.02 -509.01%-0.01 -303.39%-0.01 -4,299.75%-0.2767 -0.1251 -0.1508 -0.0016 -0.0025
Basic earnings per share 81.93%-0.05 92.00%-0.01 86.74%-0.02 -509.01%-0.01 -303.39%-0.01 -4,299.75%-0.2767 -0.1251 -0.1508 -0.0016 -0.0025
Dividend per share
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes -- -- -- -- Unqualified Opinion with Explanatory Notes -- -- -- --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data